TESALYS
Activities
Our equipment is designed to treat infectious waste produced by healthcare, analysis and research establishments directly on the production site. Our shredding and sterilization pre-treatment technology is a direct alternative to incineration, significantly reducing the volume and weight of waste. The costs and risks associated with the
storage, transportation and disposal of your hazardous waste are thus limited. On-site treatment allows a significant reduction of the carbon footprint.
Key figures
- Staff
- 20
References
We export 98% of our turnover, we have more than 400 machines installed in 62 countries in the five continents. We have a network of authorized distributors spanning 90 countries and our multilingual sales and technical teams travel regularly to support our distributors and customers around the world.
Already distributed in Western Europe, Eastern Europe, North Africa, Central Africa, Middle East, Central Asia, South East Asia, Central America and South America. Our international distribution network is constantly expanding in order to eventually cover the entire market.
Intervention domains
Waste from care activities that pose a risk of infectionCertifications, labels or price
Tesalys IHCW treatment systems were the first to miniaturize the crushing and sterilization process allowing waste treatment as close as possible to the place of production. R&D is in Tesalys’ DNA, we have 6 patents on technology and 20% of our workforce is dedicated to research and development.
We have been certified ISO 9001 in 2021, guaranteeing the quality of our products, our services and our internal processes.